LTA4H and ovarian carcinoma: An article entitled “Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin” discusses the establishment of a prognosis model for ovarian cancer based on pufa-related genes, the role of the downstream LTA4H gene in the progression and drug resistance of ovarian cancer, and potential treatment strategies for ovarian cancer (80).